UNSPSC 51271632: Octacaine hydrochloride

This classification denotes an anesthetic agent C14H22N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9HKU5M1CEM, chemically known as butanamide, 3-(diethylamino)-n-phenyl-, hydrochloride (1:1), but more generally known as octacaine hydrochloride, which bears US NIH Compound Identifier 159597. Most nations, for tariff and trade purposes, schedule octacaine hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, OCTACAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

SMILES: CCN(CC)C(C)CC(=O)NC1CCCCC1.CL.

UNSPSC 51271632 Octacaine hydrochloride is a Commodity code covering a local anesthetic pharmaceutical used in medical and dental procedures. State and local governments procure octacaine hydrochloride primarily through health departments, public health clinics, correctional facilities, and hospital systems for use in minor surgical procedures, dental work, and wound care. The drug is supplied as injectable solution in single-use vials or multi-dose containers, typically through standing supply agreements or blanket purchase orders rather than project-specific solicitations.

The source provides no recent state and local contract opportunities tagged to this code. Without posted RFPs, RFQs, IBFs, or ITBs in the recent-opportunities block, the current procurement activity under UNSPSC 51271632 cannot be characterized by issuing-body mix, geographic spread, or representative solicitation examples. Buyers pursuing this commodity should monitor state health department procurement portals, correctional-system supplier networks, and cooperative purchasing vehicles (such as state-led health consortia) for standing offers and blanket-order renewals, as pharmaceutical procurement for this class of drug typically operates through ongoing supply schedules rather than time-bounded competitive notices.